On Wednesday, Shares of Microsoft Corporation (NASDAQ:MSFT), gained 3.68% to $43.36.
SPYRUS declared the world’s first 512 GB high-capacity Microsoft (MSFT) Windows® 10 certified Windows To Go SSD live drives. The Portable Workplace™, Secure Portable Workplace™, WorkSafe™, and WorkSafe Pro™ devices extend the SPYRUS family of 32, 64, 128, and 256 GB versions to address a rapidly developing need for large memory capacity to address local data analytics processing and on-demand data mining among a mobile workforce. The value of this data requires a solution that transforms almost any laptop or desktop into a trustworthy workspace to protect this valued content and the resultant critical business information.
SPYRUS devices enable immediate, economical, low-friction deployment of highly secure, high-capacity Windows 10 computing environments — fully provisioned and fully functional within hours vs. weeks for traditional approaches. Organizations gain new agility to provision (and decommission) contractors, remote workers and telecommuters with a complete operating environment that comprises global end-point support securely and centrally managed by the SPYRUS Enterprise Administration System. The SPYRUS products have all successfully passed a battery of stringent MILSPEC 810 and related environmental and security requirements.
Microsoft Corporation, a technology company, develops, licenses, and supports software products, services, and devices worldwide. The company’s Devices and Consumer (D&C) Licensing segment licenses Windows operating system and related software; Microsoft Office for consumers; and Windows Phone operating system.
Shares of Hospira Inc. (NYSE:HSP), remained flat to $89.95, during its last trading session.
Hospira declared the first installation of the Plum 360™ infusion system with Hospira MedNet™, at Shannon Medical Center in San Angelo, Texas. The Plum 360 infusion system, supported by the new Hospira MedNet version 6.1 safety software, is the latest addition to Hospira’s innovative portfolio of next-generation smart pumps.
“Hospira is excited to partner with Shannon Medical Center on the launch of the new Plum general infusion device,” said Cynthia Ansari, vice president, U.S. Marketing and Software, Medical Devices, Hospira. “This marks another important step on Hospira’s journey towards offering the newest, most advanced line of infusion devices available. Designed with close attention to the clinical needs of our customers, the Plum 360 infusion system delivers advanced capabilities to enable clinical excellence, counting automatic default into an improved Hospira MedNet drug library.”
Hospira, Inc. provides injectable drugs and infusion technologies to develop, manufacture, distribute, and market products worldwide. The company operates through Americas, EMEA, and APAC segments. It provides specialty injectable pharmaceuticals, which comprise about 200 injectable generic drugs in multiple dosages and formulations; and proprietary specialty injectables, such as Precedex, a proprietary drug for sedation.
Finally, Joy Global, Inc. (NYSE:JOY), ended its last trade with 0.14% gain, and closed at $22.13, hitting its lowest level.
Joy Global stated third quarter fiscal 2015 results.
Third Quarter Summary
- Bookings $635 million, down 31 percent from a year ago
- Service bookings $537 million, down 16 percent from a year ago
- Net sales $792 million, down 10 percent from a year ago
- Earnings per diluted share $0.46, contrast to $0.71 a year ago
- Not taking into account excess purchase accounting, acquisition costs, restructuring charges and pension items of $14 million, adjusted earnings per diluted share of $0.54, contrast to $0.80 a year ago
- Net cash offered by operations $116 million, up 27% from a year ago
Joy Global Inc. manufactures and services mining equipment for the extraction of coal, copper, iron ore, oil sands, gold, and other minerals. It operates in two segments, Underground Mining Machinery and Surface Mining Equipment.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
